Որոնման արդյունքները - Allison Roebuck
- Ցուցադրվում են 1 - 2 արդյունքները 2
-
1
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab... Zhigang Liu, Kaixing Le, Xin Zhou, James L. Alexander, Simeng Lin, Claire Bewshea, Neil Chanchlani, Rachel Nice, Timothy J. McDonald, Christopher A Lamb, Shaji Sebastian, Klaartje Kok, Charlie W. Lees, Ailsa Hart, Richard Pollok, Rosemary J. Boyton, Daniel M. Altmann, Katrina M. Pollock, James Goodhand, Nicholas A. Kennedy, Tariq Ahmad, Nick Powell, Madiha Islam, Nick Croft, Bessie Cipriano, C. Francia, Nosheen Khalid, Ashley Kingston, Irish Lee, Anouk Lehmann, Kinnari Naik, Kevin Samuels, Nicolene Plaatjies, Hafiza Khatun, Farjana Bokth, Elise Pabriaga, Rebecca Saich, Hayley Cousins, Wendy Fraser, Rachel Thomas, Matthew A. Brown, Benjamin White, Nikolaos Kirkineziadis, Bernadette Tilley, Pennie Porter, Rachel Bryant, Natalia Robaczewska, Rafeeq Muhammed, Rehana Bi, Catherine Cotter, Jayne Grove, Kate Hong, Ruth Howman, Monica J. Mitchell, Sophie Clayton, Louise Rogers, Sugrah Sultan, Melanie Rooney, Charlotte Cottrill, Salil Singh, Chris Dawe, R. Hull, Nataliê Silva, Julie Chadwick, L. Robertson, Jonathan Manning, Lauren Finlayson, Allison Roebuck, Joy Dawson, Sunil Sonwalkar, Naomi Chambers, Matthew Robinson, Andrew Haigh, Lear Matapure, Tim Raine, Varun George, Christina Kapizioni, Konstantina Strongili, Tina L. Thompson, Mohamed Ahmed, Christos K. Kontos, Claire Dawson, Christophe Bourges, Isabella Barbutti, Megan E. Gozzard, Philip Hendy, Rhian Bull, Patricia Costa, Lisa Davey, Hayley Hannington, Kribashnie Nundlall, Catarina Martins, Laura Avanzi, Jaime Carungcong, Sabrina Barr, Richard Appleby, Emma C. Johnson, Eathar Shakweh, Kath Phillis, Rachel Gascoyne
Հրապարակվել է 2022Artigo -
2
Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab Simeng Lin, Nicholas A. Kennedy, Aamir Saifuddin, Diana Muñoz Sandoval, Catherine J. Reynolds, Rocio Castro Seoane, Sherine Hermangild Kottoor, Franziska P. Pieper, Kai‐Min Lin, David K. Butler, Neil Chanchlani, Rachel Nice, Desmond Chee, Claire Bewshea, Malik Janjua, Timothy J. McDonald, Shaji Sebastian, James L. Alexander, Laura Constable, James Lee, Charles Murray, Ailsa Hart, Peter M. Irving, Gareth‐Rhys Jones, Klaartje Kok, Christopher A Lamb, Charlie W. Lees, Daniel M. Altmann, Rosemary J. Boyton, James Goodhand, Nick Powell, Tariq Ahmad, Klaartje Kok, Farjhana Bokth, Bessie Cipriano, C. Francia, Nosheen Khalid, Hafiza Khatun, Ashley Kingston, Irish Lee, Anouk Lehmann, Kinnari Naik, Elise Pabriaga, Nicolene Plaatjies, Kevin Samuels, Rebecca Saich, Hayley Cousins, Wendy Fraser, Rachel Thomas, Matthew A. Brown, Benjamin White, Nikolaos Kirkineziadis, Bernadette Tilley, Rafeeq Muhammed, Rehana Bi, Catherine Cotter, Jayne Grove, Kate Hong, Ruth Howman, Monica J. Mitchell, Sophie Clayton, Sugrah Sultan, Melanie Rooney, Charlotte Cottrill, Salil Singh, Chris Dawe, R. Hull, Nataliê Silva, Jonathan Manning, Lauren Finlayson, Allison Roebuck, Joy Dawson, Sunil Sonwalkar, Naomi Chambers, Matthew Robinson, Andrew Haigh, Lear Matapure, Tim Raine, Varun George, Christina Kapizioni, Konstantina Strongili, Tina L. Thompson, Mohamed Ahmed, Christos K. Kontos, Christophe Bourges, Isabella Barbutti, Megan E. Gozzard, Philip Hendy, Rhian Bull, Patricia Costa, Lisa Davey, Hayley Hannington, Kribashnie Nundlall, Catarina Martins, Laura Avanzi, Jaime Carungcong, Sabrina Barr, Richard Appleby, Emma C. Johnson, Kath Phillis
Հրապարակվել է 2022Artigo
Որոնման գործիքներ:
Առնչվող խորագիր
Antibody
Disease
Immunology
Inflammatory bowel disease
Infliximab
Internal medicine
Medicine
Tumor necrosis factor alpha
Vedolizumab
Virology
Antibody therapy
Coronavirus disease 2019 (COVID-19)
Drug
Immune system
Immunity
Infectious disease (medical specialty)
Monoclonal antibody
Pharmacology
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Vaccination